Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1996 Apr;72(846):229–230. doi: 10.1136/pgmj.72.846.229

Minoxidil, hypercoagulability and thromboembolic disease of the lung.

S G Keohane 1, M Edmunds 1, J Holton 1, J D Swales 1
PMCID: PMC2398428  PMID: 8733532

Abstract

Minoxidil is a potent antihypertensive agent used in the treatment of resistant hypertension. A case is presented which illustrates a probably fatal interaction between minoxidil and a coagulation disorder.

Full text

PDF
229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Franciosa J. A., Dunkman W. B., Leddy C. L. Hemodynamic effects of vasodilators and long-term response in heart failure. J Am Coll Cardiol. 1984 Jun;3(6):1521–1530. doi: 10.1016/s0735-1097(84)80292-2. [DOI] [PubMed] [Google Scholar]
  2. Jett G. K., Herman E. H., Jones M., Ferrans V. J., Clark R. E. Influence of minoxidil on myocardial hemodynamics, regional blood flow, and morphology in beagle dogs. Cardiovasc Drugs Ther. 1988 Mar;1(6):687–694. doi: 10.1007/BF02125757. [DOI] [PubMed] [Google Scholar]
  3. Macdonald G., Walker T., Assef R., Duggan K. Uridine kinase inhibition is involved in the vasodilator effects of minoxidil in the rat. Clin Exp Pharmacol Physiol. 1990 Apr;17(4):287–290. doi: 10.1111/j.1440-1681.1990.tb01322.x. [DOI] [PubMed] [Google Scholar]
  4. Sobota J. T., Martin W. B., Carlson R. G., Feenstra E. S. Minoxidil: right atrial cardiac pathology in animals and in man. Circulation. 1980 Aug;62(2):376–387. doi: 10.1161/01.cir.62.2.376. [DOI] [PubMed] [Google Scholar]
  5. Sobota J. T. Review of cardiovascular findings in humans treated with minoxidil. Toxicol Pathol. 1989;17(1 Pt 2):193–202. doi: 10.1177/019262338901700115. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES